In July 2005, Griffiths organized the advocacy group “Fighting for Herceptin” and successful lobbied the British Parliament after the NHS refused her request to for the life-prolonging breast cancer drug Herceptin because of the cost of the treatment.
Three years later, Dorothy continues to be a cancer survivor and advocate for women and breast cancer, pushing the NHS to offer Herceptin treatment. However, the drug can still only be prescribed to women with advanced breast cancer. Recent clinical trials overwhelmingly show that the drug also has positive effects for many women with early-stage breast cancer.
Citizens of the U.K. pay 11 percent of each pound they make in weekly income to the NHS....learn more.
The Center for Medicine in the Public Interest Advance (CMPI Advance) is a nonprofit, non-partisan 501c4 organization that sponsors the communication of ideas that focus on the understanding by policymakers, the media and the general public of medical innovation and to effect change in public health care policy in a way that makes health care more affordable, preventative and patient-centered.